Height outcomes in children with growth hormone deficiency and idiopathic short stature treated concomitantly with growth hormone and aromatase inhibitor therapy: data from the ANSWER program

BACKGROUND: Treatment of children with growth hormone deficiency (GHD) or idiopathic short stature (ISS) using GH is only effective for bone growth prior to epiphyseal fusion. Aromatase inhibitor therapy (AIT) blocks estrogen production, thereby delaying epiphyseal fusion. The current study analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Bradley S., Ross, Judith, Ostrow, Vlady
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537098/
https://www.ncbi.nlm.nih.gov/pubmed/33042202
http://dx.doi.org/10.1186/s13633-020-00089-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537098/
https://www.ncbi.nlm.nih.gov/pubmed/33042202
http://dx.doi.org/10.1186/s13633-020-00089-z

Ejemplares similares